STATE STREET CORP

State Street’s latest investments in a high‑margin beauty retailer and an AI‑powered cloud‑software firm highlight its focus on solid earnings growth, smart capital allocation and sector diversification.

Discover why State Street’s silence matters—explore regulatory shifts, tech moves, and capital strategy that could shape the custodian’s next move.

State Street boosts stakes in Monte Rosa and Cullinan, spotlighting AI‑powered drug discovery and oncology therapies for long‑term biotech growth.

State Street’s latest stake in a cloud‑based analytics platform and its lobbying in market‑infrastructure policy reveal hidden conflicts and a call for tighter transparency.

State Street launches a preferred‑stock offering via depositary shares, boosting liquidity and capital, while its growing stake in Trade Desk signals a shift in institutional holdings.

State Street boosts its stake in a leading internet service provider, weighing a 1.8% increase against rising analyst concerns over revenue and margins.

State Street expands into telecoms & gaming peripherals, balancing fee‑growth with tech equity upside while staying resilient amid tightening regulation.

Explore State Street’s 8‑K: new perpetual Series L preferred stock, a $5–$6 M depositary share offering, and fiscal‑year alignment – key for investors seeking stable, risk‑free income.

State Street’s Q2 2026 results show strong EPS, robust Basel‑III compliance, and AI‑driven RegTech—boosting client service, ESG focus and cross‑border settlement opportunities.

State Street’s 2026 Form 4 reveals a quiet insider transfer by Hu W. Bradford—yet no trade details are disclosed, raising questions about transparency, potential conflicts, and investor confidence.